KYTHERA BIOPHARMACEUTICALS INC 4
4 · KYTHERA BIOPHARMACEUTICALS INC · Filed Sep 23, 2015
Insider Transaction Report
Form 4
Klein Keith
General Counsel
Transactions
- Exercise/Conversion
Common Stock
2015-09-22$8.22/sh+10,589$87,042→ 14,657 total - Exercise/Conversion
Stock Options
2015-09-22−1,184→ 14,203 totalExercise: $8.22Exp: 2022-02-01→ Common Stock (1,184 underlying) - Gift
Common Stock
2015-09-11−2,677→ 4,068 total - Exercise/Conversion
Stock Options
2015-09-22−9,405→ 0 totalExercise: $8.22Exp: 2022-02-01→ Common Stock (9,405 underlying) - Sale
Common Stock
2015-09-22$74.90/sh−10,589$793,116→ 4,068 total
Footnotes (2)
- [F1]25% of the shares subject to the option vested on the first anniversary measured from January 1, 2012 (the "Vesting Commencement Date"), and 1/48th of the total number of shares vest in thirty-six (36) successive and equal monthly installments thereafter, such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date.
- [F2]The shares subject to these options vested 100% upon the achievement of certain performance milestones approved by the Issuer's Board of Directors.